Eagle Point Credit Company 6.50% Series C Term Preferred Stock due 2031 (ECCC)
Live price chart, market sentiment, and community perspectives for Eagle Point Credit Company 6.50% Series C Term Preferred Stock due 2031 (NYSE: ECCC).
Live price chart, market sentiment, and community perspectives for Eagle Point Credit Company 6.50% Series C Term Preferred Stock due 2031 (NYSE: ECCC).
On our desk, we are tracking ECCC closely as a stable fixed-income vehicle within the closed-end fund space. With the Series C Term Preferred Stock trading post-call date at $24.65—representing a 1.40% discount to the $25.00 liquidation preference—the current yield sits appealingly at 6.59%. Market sentiment remains cautiously constructive given the steady declaration of monthly distributions of $0.135417 through the third quarter of 2026. However, participants must remain mindful of the broader macro environment where economic risks and potential market volatility could influence closed-end asset valuations.
From a risk management standpoint, analyzing Eagle Point Credit Company requires looking past the headline preferred yields and evaluating the underlying collateral. ECCC relies on a portfolio heavily exposed to equity and junior debt tranches of CLOs, which feature a weighted average loan rating of B+/B and an average remaining CLO reinvestment period of 3.4 years. While the cumulative nature of the preferred stock and regular distribution announcements provide income visibility up to the June 30, 2031 maturity date, the speculative nature of the underlying collateral pool introduces structural vulnerabilities that require ongoing portfolio health monitoring.
When evaluating fixed-income instruments like ECCC for a rotation strategy, my quantitative protocol centers on spread distribution, liquidation preference discounts, and cash flow timing. ECCC offers a clear payment schedule with monthly distributions backed by a 6.50% original coupon. Analysts evaluating this instrument should verify the exact ex-dividend dates and record schedules—such as the recent September 10, 2026 ex-date—while cross-referencing the broader capital structure, which includes multiple series of notes and preferred shares across the Eagle Point ecosystem.
Explore plasma cleansing, somatic organ swaps, and BCI.